HCA / HCA Healthcare, Inc. - Документы SEC, Годовой отчет, Доверенное заявление

- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthc

List of Subsidiary Guarantors and Pledged Securities.

EXHIBIT 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

Balance Sheet and Cash Flows from Operations Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare reports SECOND quarter 2025 results RAISES 2025 Guidance Nashville, Tenn., July 25, 2025 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2025. Key second quarter metrics (all percentage ch

FORM 8-K Item 2.02. Results of Operations and Financial Condition. Item 7.01. Regulation FD Disclosure. Item 8.01. Other Events. Item 9.01. Financial Statements and Exhibits. (d) Exhibits:

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2025 HCA Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 11, 2025 (July 8, 2025) HCA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 11, 2025 (July 8, 2025) HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (

HCA HEALTHCARE APPOINTS JOHN W. CHIDSEY, III AS NEW INDEPENDENT DIRECTOR

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford     615-344-2688 615-344-1851 HCA HEALTHCARE APPOINTS JOHN W. CHIDSEY, III AS NEW INDEPENDENT DIRECTOR NASHVILLE, Tenn., July 11, 2025 – HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey

As Filed With the Securities and Exchange Commission on June 23, 2025

As Filed With the Securities and Exchange Commission on June 23, 2025 Registration No.

Filing Fee Table.

Calculation of Filing Fee Tables S-8 HCA Healthcare, Inc. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common Stock, $.01 par value per share Other 13,150,000 $ 362.41 $ 4,765,691,500.00 0.0001531 $ 729,627.37 Total

Amended and Restated Certificate of Incorporation of the Company (restated for SEC filing purposes only).

Exhibit 4.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HCA HEALTHCARE, INC. ARTICLE I NAME The name of the Corporation is HCA Healthcare, Inc. (hereinafter, the “Corporation”). ARTICLE II REGISTERED OFFICE AND AGENT The address of the Corporation’s registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, Wilmington, New Castle County, Delaware 19801. Th

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 10, 2025 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission File

List of Subsidiary Guarantors and Pledged Securities.

EXHIBIT 22 List of Subsidiary Guarantors All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthca

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 29, 2025 (April 24, 2025) HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation

Certificate of Amendment to Amended and Restated Certificate of Incorporation of HCA Healthcare, Inc., as filed with the Secretary of State of Delaware on April 24, 2025 with an effective date of April 25, 2025.

EX-3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF HCA HEALTHCARE, INC. Pursuant to the provisions of Section 242 of the General Corporation Law of the State of Delaware, HCA Healthcare, Inc., a corporation duly organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: A. The name of the Cor

First Amendment to 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.

EX-10.1 Exhibit 10.1 FIRST AMENDMENT TO THE 2020 STOCK INCENTIVE PLAN FOR KEY EMPLOYEES OF HCA HEALTHCARE, INC. AND ITS AFFILIATES Effective as of April 24, 2025 WHEREAS, HCA Healthcare, Inc., a Delaware corporation (the “Company”), has previously adopted the Company’s 2020 Stock Incentive Plan For Key Employees of HCA Healthcare, Inc. and its Affiliates (the “Plan”); WHEREAS, pursuant to Section

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 25, 2025 HCA Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission Fil

Balance Sheet and Cash Flows from Operations Dividend

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare reports FIRST quarter 2025 results Nashville, Tenn., April 25, 2025 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant  ☒ Filed by a party other than the Registrant  ☐ Check the a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant  ☒ Filed by a party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Sta

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   ☒ Filed by a party other than the Registrant   ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   ☒ Filed by a party other than the Registrant   ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 24, 2025 (February 18, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 24, 2025 (February 18, 2025) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorpo

HCA Healthcare, Inc. 2025 Executive Officer Performance Excellence Program

Exhibit 10.1 HCA HEALTHCARE, INC. 2025 EXECUTIVE OFFICER PERFORMANCE EXCELLENCE PROGRAM Purpose and Administration of the Program The 2025 Executive Officer Performance Excellence Program (the “Program”) has been established by HCA Healthcare, Inc. (the “Company”) to encourage outstanding performance from its executive officers. Awards under the Program shall be administered as “Performance-Based

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2025 (February 18, 2025) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporati

Supplemental Indenture No. 45, dated as of February 21, 2025, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent

Exhibit 4.3 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent FLOATING RATE SENIOR NOTES DUE 2028 SUPPLEMENTAL INDENTURE NO. 45 Dated as of February 21, 2025 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indentur

Supplemental Indenture No. 47, dated as of February 21, 2025, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent

Exhibit 4.5 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.500% SENIOR NOTES DUE 2032 SUPPLEMENTAL INDENTURE NO. 47 Dated as of February 21, 2025 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act S

Underwriting Agreement, dated as of February 18, 2025, among HCA Inc., HCA Healthcare, Inc., and BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities, LLC as representatives of the other several underwriters named therein

Exhibit 1.1 Execution Version HCA INC. $700,000,000 5.000% Senior Notes due 2028 $300,000,000 Floating Rate Senior Notes due 2028 $750,000,000 5.250% Senior Notes due 2030 $750,000,000 5.500% Senior Notes due 2032 $1,500,000,000 5.750% Senior Notes due 2035 $1,250,000,000 6.200% Senior Notes due 2055 UNDERWRITING AGREEMENT February 18, 2025 BofA Securities, Inc. Barclays Capital Inc. Citigroup Glo

Supplemental Indenture No. 44, dated as of February 21, 2025, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent

Exhibit 4.2 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.000% SENIOR NOTES DUE 2028 SUPPLEMENTAL INDENTURE NO. 44 Dated as of February 21, 2025 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act S

Supplemental Indenture No. 49, dated as of February 21, 2025, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent

Exhibit 4.7 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 6.200% SENIOR NOTES DUE 2055 SUPPLEMENTAL INDENTURE NO. 49 Dated as of February 21, 2025 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act S

Supplemental Indenture No. 48, dated as of February 21, 2025, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent

Exhibit 4.6 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.750% SENIOR NOTES DUE 2035 SUPPLEMENTAL INDENTURE NO. 48 Dated as of February 21, 2025 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act S

Supplemental Indenture No. 46, dated as of February 21, 2025, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent

Exhibit 4.4 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.250% SENIOR NOTES DUE 2030 SUPPLEMENTAL INDENTURE NO. 46 Dated as of February 21, 2025 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act S

Credit Agreement dated as of February 20, 2025, by and among HCA Inc., as borrower, Bank of America, N.A., as administrative agent, and the lenders party thereto

Exhibit 10.1 Published CUSIP No.: [    ] CREDIT AGREEMENT Dated as of February 20, 2025, among HCA INC., as the Borrower, The Several Lenders from Time to Time Parties Hereto, BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and Letter of Credit Issuer, and BOFA SECURITIES, INC., WELLS FARGO SECURITIES, LLC, BARCLAYS BANK PLC, CITIBANK, N.A., JPMORGAN CHASE BANK, N.A. and MIZUHO BA

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 20, 2025 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission

HCA Inc. $5,250,000,000 Senior Notes Consisting of: $700,000,000 5.000% Senior Notes due 2028 $300,000,000 Floating Rate Senior Notes due 2028 $750,000,000 5.250% Senior Notes due 2030 $750,000,000 5.500% Senior Notes due 2032 $1,500,000,000 5.750% S

Filed Pursuant to Rule 424(b)(5) Registration No. 333-271537 PROSPECTUS SUPPLEMENT (To Prospectus dated May 1, 2023) HCA Inc. $5,250,000,000 Senior Notes Consisting of: $700,000,000 5.000% Senior Notes due 2028 $300,000,000 Floating Rate Senior Notes due 2028 $750,000,000 5.250% Senior Notes due 2030 $750,000,000 5.500% Senior Notes due 2032 $1,500,000,000 5.750% Senior Notes due 2035 $1,250,000,0

Calculation of Filing Fee Tables (Form Type) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

EXHIBIT 107 Calculation of Filing Fee Tables 424(b)(5) (Form Type) HCA Healthcare, Inc.

HCA Inc. $700,000,000 5.000% Senior Notes due 2028 (the “2028 notes”) $300,000,000 Floating Rate Senior Notes due 2028 (the “floating rate notes”) $750,000,000 5.250% Senior Notes due 2030 (the “2030 notes”) $750,000,000 5.500% Senior Notes due 2032

Filed pursuant to Rule 433 Issuer Free Writing Prospectus, dated February 18, 2025 Supplementing the Preliminary Prospectus Supplement, dated February 18, 2025 Registration No.

HCA ANNOUNCES PROPOSED PUBLIC OFFERING OF SENIOR NOTES

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT:   Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA ANNOUNCES PROPOSED PUBLIC OFFERING OF SENIOR NOTES NASHVILLE, Tenn., February 18, 2025 – HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actu

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 18, 2025 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission

Subject to Completion, dated February 18, 2025

424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-271537 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are part of an effective registration statement filed with the Securities and Exchange Commission. This preliminary prospectus supplement and the acco

Schedule of Omitted Supplements to the Pledge Agreement, dated as of November 6, 2006 and amended and restated as of March 2, 2009, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.7(c) Schedule of Omitted Supplements to Pledge Agreement The supplements to the pledge agreement referenced below are substantially identical in all material respects to the Supplement No. 1 dated as of October 27, 2011 to the Pledge Agreement dated as of November 6, 2006, and amended and restated as of March 2, 2009, as supplemented (the “Pledge Agreement”) and filed as Exhibit 4.7(b) t

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11239 HCA Healthcare, I

Schedule of Omitted Supplements to the Security Agreement dated as of September 30, 2011, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.9(c) Schedule of Omitted Supplements to Security Agreement The supplements to the security agreement referenced below are substantially identical in all material respects to the Supplement No. 1 dated as of October 27, 2011 to the Security Agreement dated as of September 30, 2011, as supplemented (the “Security Agreement”) and filed as Exhibit 4.9(b) to the Company’s annual report on For

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

HCA Healthcare, Inc. Securities Trading Policy.

Exhibit 19 DEPARTMENT: Legal POLICY DESCRIPTION: Securities Trading PAGE: 1 of 12 REPLACES POLICY DATED: 1/30/04, 9/1/05, 1/17/06, 3/9/11, 4/26/12, 2/1/13, 1/29/15, 7/21/16, 1/25/19, 4/19/23 EFFECTIVE DATE January 23, 2025 REFERENCE NUMBER: LL.

Schedule of Omitted Supplements to the Security Agreement, dated as of November 17, 2006 and amended and restated as of March 2, 2009, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.6(c) Schedule of Omitted Supplements to Security Agreement The supplements to the security agreement referenced below are substantially identical in all material respects to the Supplement No. 2 dated as of October 27, 2011 to the Security Agreement dated as of November 17, 2006, amended and restated as of March 2, 2009, as supplemented (the “Security Agreement”) and filed as Exhibit 4.6

Schedule of Omitted Supplements to the U.S. Guarantee, dated as of November 17, 2006 and amended and restated on February 26, 2014, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.5(k) Schedule of Omitted Supplements to U.S. Guarantee Agreement The supplements to the U.S. guarantee agreement referenced below are substantially identical in all material respects to the Supplement No. 14 dated as of November 9, 2015 to the U.S. Guarantee dated as of November 17, 2006, as amended and restated as of February 26, 2014, as supplemented (the “U.S. Guarantee Agreement”) an

Form of 2025 Stock Appreciation Right Award Agreement under the 2020 Stock Incentive Plan for

Exhibit 10.43 Form of HCA Healthcare, Inc. Stock Appreciation Rights Agreement This STOCK APPRECIATION RIGHTS AGREEMENT (the “Agreement”), dated as of (the “Grant Date”) is made by and between HCA Healthcare, Inc., a Delaware corporation (together with its Subsidiaries, Successors and other applicable Service Recipients, hereinafter referred to as the “Company”), and the individual whose name is s

Form of 2025 Performance Share Unit Award Agreement Under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.*

Exhibit 10.44 Form of HCA Healthcare, Inc. Performance Share Unit Agreement This PERFORMANCE SHARE UNIT AGREEMENT (this “Agreement”) is made and entered into as of the day of , 20 (the “Grant Date”), between HCA Healthcare, Inc., a Delaware corporation (together with its Subsidiaries, Successors and other applicable Service Recipients, as applicable, the “Company”), and [Participant Name], (the “G

List of Subsidiaries.

Exhibit 21 ALABAMA CareOne Home Health Services, Inc. Four Rivers Medical Center PHO, Inc. Selma Medical Center Hospital, Inc. ALASKA Alaska Regional Medical Group, LLC Alaska Spine Center, LLC Anchorage Surgicenter, LLC Chugach PT, Inc. Columbia Behavioral Healthcare, Inc. SLS Mountain Division, LLC Surgicare of Anchorage, LLC ARIZONA DS Real Estate Holdings, LLC Urgent Care Extra - Ann & Simmons

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2025 HCA Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission F

HCA Healthcare reports FOURTH quarter 2024 results AND PROVIDES 2025 GUIDANCE

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare reports FOURTH quarter 2024 results AND PROVIDES 2025 GUIDANCE Nashville, Tenn., January 24, 2025 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024. Key fourth quarter metrics (all

List of Subsidiary Guarantors and Pledged Securities.

EXHIBIT 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA He

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2024 HCA Healthcare, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 1-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission Fil

HCA Healthcare reports THIRD quarter 2024 results

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare reports THIRD quarter 2024 results Nashville, Tenn., October 25, 2024 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2024. Key third quarter metrics (all percentage changes compare 3Q

Supplemental Indenture No. 42, dated as of August 12, 2024, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent

Exhibit 4.5 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.450% SENIOR NOTES DUE 2034 SUPPLEMENTAL INDENTURE NO. 42 Dated as of August 12, 2024 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Sec

Supplemental Indenture No. 43, dated as of August 12, 2024, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on August 12, 2024, and incorporated herein by reference).

Exhibit 4.6 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.950% SENIOR NOTES DUE 2054 SUPPLEMENTAL INDENTURE NO. 43 Dated as of August 12, 2024 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Sec

Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 12, 2024 (August 12, 2024) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation)

Supplemental Indenture No. 41, dated as of August 12, 2024, among HCA Inc., HCA Healthcare, Inc., CSC Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on August 12, 2024, and incorporated herein by reference).

Exhibit 4.4 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, CSC DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.450% SENIOR NOTES DUE 2031 SUPPLEMENTAL INDENTURE NO. 41 Dated as of August 12, 2024 To BASE INDENTURE Dated as of August 1, 2011 SUPPLEMENTAL INDENTURE NO. 41 (the “Forty-Firs

Calculation of Filing Fee Tables (Form Type) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

EXHIBIT 107 Calculation of Filing Fee Tables 424(b)(5) (Form Type) HCA Healthcare, Inc.

HCA Inc. $3,000,000,000 Senior Notes Consisting of: $750,000,000 5.450% Senior Notes due 2031 $1,250,000,000 5.450% Senior Notes due 2034 $1,000,000,000 5.950% Senior Notes due 2054

424B5 Filed Pursuant to Rule 424(b)(5) Registration No. 333-271537 PROSPECTUS SUPPLEMENT (To Prospectus dated May 1, 2023) HCA Inc. $3,000,000,000 Senior Notes Consisting of: $750,000,000 5.450% Senior Notes due 2031 $1,250,000,000 5.450% Senior Notes due 2034 $1,000,000,000 5.950% Senior Notes due 2054 HCA Inc. is offering $750,000,000 aggregate principal amount of 5.450% Senior Notes due 2031, w

Underwriting Agreement, dated as of August 7, 2024, among HCA Inc., HCA Healthcare, Inc., and Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the other several underwriters named therein.

EX-1.1 Exhibit 1.1 Execution Version HCA INC. $750,000,000 5.450% Senior Notes due 2031 $1,250,000,000 5.450% Senior Notes due 2034 $1,000,000,000 5.950% Senior Notes due 2054 UNDERWRITING AGREEMENT August 7, 2024 Citigroup Global Markets Inc. BofA Securities, Inc. J.P. Morgan Securities LLC Wells Fargo Securities, LLC As Representatives of the Underwriters c/o Citigroup Global Markets Inc. 388 Gr

HCA Inc. $750,000,000 5.450% Senior Notes due 2031 (the “new 2031 notes”) $1,250,000,000 5.450% Senior Notes due 2034 (the “2034 notes”) $1,000,000,000 5.950% Senior Notes due 2054 (the “2054 notes”) (collectively, the “notes”) Pricing Supplement

Filed pursuant to Rule 433 Issuer Free Writing Prospectus, dated August 7, 2024 Supplementing the Preliminary Prospectus Supplement, dated August 7, 2024 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2024 (August 7, 2024) H

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 8, 2024 (August 7, 2024) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (C

Subject to Completion, dated August 7, 2024

Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-271537 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are part of an effective registration statement filed with the Securities and Exchange Commission. This preliminary prospectus supplement and the accompanyi

- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthc

List of Subsidiary Guarantors and Pledged Securities.

EXHIBIT 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 23, 2024 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission File

HCA HEALTHCARE REPORTS SECOND QUARTER 2024 RESULTS RAISES 2024 GUIDANCE

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS SECOND QUARTER 2024 RESULTS RAISES 2024 GUIDANCE Nashville, Tenn., July 23, 2024 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2024. Key second quarter metrics (all percentage ch

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthca

List of Subsidiary Guarantors and Pledged Securities.

EXHIBIT 22 List of Subsidiary Guarantors All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 30, 2024 (April 25, 2024) HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation

HCA HEALTHCARE REPORTS FIRST QUARTER 2024 RESULTS

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS FIRST QUARTER 2024 RESULTS Nashville, Tenn., April 26, 2024 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024. Key first quarter metrics (all percentage changes compare

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 26, 2024 HCA HEALTHCARE, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 26, 2024 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission Fil

“RESOLVED: Shareholders of HCA Healthcare Inc. (the “Company”) request that its Board of Directors publish a report (at reasonable expense and omitting proprietary and personally protected information) describing feedback the Company receives from pa

Notice of Exempt Solicitation Pursuant to Rule 14a-103 NAME OF THE REGISTRANT: HCA Healthcare, Inc.

United States Securities and Exchange Commission Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Pursuant to Rule 14a-103

PX14A6G 1 z327242px14a6g.htm United States Securities and Exchange Commission Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Pursuant to Rule 14a-103 Name of the Registrant: HCA Healthcare, Inc. Name of persons relying on exemption: Rhia Ventures Address of persons relying on exemption: 47 Kearny Street, San Francisco, CA 94108 Written materials are submitted pursuant to Rule 14a-6(g) (1) pr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   ☒ Filed by a party other than the Registrant   ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant  ☒ Filed by a party other than the Registrant  ☐ Check the a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant  ☒ Filed by a party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Sta

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 26, 2024 (January 24, 2024) HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdic

HCA Healthcare, Inc. 2024 Executive Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on February 26, 2024, and incorporated herein by reference).*

Exhibit 10.1 HCA HEALTHCARE, INC. 2024 EXECUTIVE OFFICER PERFORMANCE EXCELLENCE PROGRAM Purpose and Administration of the Program The 2024 Executive Officer Performance Excellence Program (the “Program”) has been established by HCA Healthcare, Inc. (the “Company”) to encourage outstanding performance from its executive officers. Awards under the Program shall be administered as “Performance-Based

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 26, 2024 (February 22, 2024) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorpo

Supplemental Indenture No. 39, dated as of February 23, 2024, among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on February 23, 2024, and incorporated herein by reference).

EX-4.4 Exhibit 4.4 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 6.000% SENIOR NOTES DUE 2054 SUPPLEMENTAL INDENTURE NO. 39 Dated as of February 23, 2024 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Ac

Supplemental Indenture No. 38, dated as of February 23, 2024, among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed on February 23, 2024, and incorporated herein by reference).

EX-4.3 Exhibit 4.3 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.600% SENIOR NOTES DUE 2034 SUPPLEMENTAL INDENTURE NO. 38 Dated as of February 23, 2024 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Ac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2024 (February 23, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 23, 2024 (February 23, 2024) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporati

Supplemental Indenture No. 37, dated as of February 23, 2024, among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on February 23, 2024, and incorporated herein by reference).

EX-4.2 Exhibit 4.2 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.450% SENIOR NOTES DUE 2031 SUPPLEMENTAL INDENTURE NO. 37 Dated as of February 23, 2024 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Ac

Supplemental Indenture No. 40, dated as of February 23, 2024, among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on February 23, 2024, and incorporated herein by reference).

EX-4.5 Exhibit 4.5 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 6.100% SENIOR NOTES DUE 2064 SUPPLEMENTAL INDENTURE NO. 40 Dated as of February 23, 2024 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Ac

Calculation of Filing Fee Tables (Form Type) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

EXHIBIT 107 Calculation of Filing Fee Tables 424(b)(5) (Form Type) HCA Healthcare, Inc.

HCA Inc. $4,500,000,000 Senior Notes Consisting of: $1,000,000,000 5.450% Senior Notes due 2031 $1,300,000,000 5.600% Senior Notes due 2034 $1,500,000,000 6.000% Senior Notes due 2054 $700,000,000 6.100% Senior Notes due 2064

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-271537 PROSPECTUS SUPPLEMENT (To Prospectus dated May 1, 2023) HCA Inc. $4,500,000,000 Senior Notes Consisting of: $1,000,000,000 5.450% Senior Notes due 2031 $1,300,000,000 5.600% Senior Notes due 2034 $1,500,000,000 6.000% Senior Notes due 2054 $700,000,000 6.100% Senior Notes due 2064 HCA Inc. is offering $1,000,000,000 agg

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2024 (February 20, 2

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 21, 2024 (February 20, 2024) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporati

HCA Inc. $1,000,000,000 5.450% Senior Notes due 2031 (the “2031 notes”) $1,300,000,000 5.600% Senior Notes due 2034 (the “2034 notes”) $1,500,000,000 6.000% Senior Notes due 2054 (the “2054 notes”) $700,000,000 6.100% Senior Notes due 2064 (the “2064

Filed pursuant to Rule 433 Issuer Free Writing Prospectus, dated February 20, 2024 Supplementing the Preliminary Prospectus Supplement, dated February 20, 2024 Registration No.

Underwriting Agreement, dated as of February 20, 2024, among HCA Inc., HCA Healthcare, Inc., and BofA Securities, Inc., Barclays Capital Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC as representatives of the other several underwriters named therein.

EX-1.1 Exhibit 1.1 Execution Version HCA INC. $1,000,000,000 5.450% Senior Notes due 2031 $1,300,000,000 5.600% Senior Notes due 2034 $1,500,000,000 6.000% Senior Notes due 2054 $700,000,000 6.100% Senior Notes due 2064 UNDERWRITING AGREEMENT February 20, 2024 BofA Securities, Inc. Barclays Capital Inc. Citigroup Global Markets Inc. J.P. Morgan Securities LLC As Representatives of the Underwriters

Subject to Completion, dated February 20, 2024

Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-271537 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are part of an effective registration statement filed with the Securities and Exchange Commission. This preliminary prospectus supplement and the accompanyi

Schedule of Omitted Supplements to the Security Agreement, dated as of November 17, 2006 and amended and restated as of March 2, 2009, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.6(c) Schedule of Omitted Supplements to Security Agreement The supplements to the security agreement referenced below are substantially identical in all material respects to the Supplement No. 2 dated as of October 27, 2011 to the Security Agreement dated as of November 17, 2006, amended and restated as of March 2, 2009, as supplemented (the “Security Agreement”) and filed as Exhibit 4.6

HCA Healthcare, Inc. Compensation Recoupment Policy.

Exhibit 97 HCA Healthcare, Inc. Compensation Recoupment Policy 1. Purpose. The purpose of this Compensation Recoupment Policy of the Company (as amended from time to time, the “Policy”), dated as of November 27, 2023, is to describe the circumstances in which Executive Officers will be required to repay or return Erroneously Awarded Compensation to members of the Company. The Company has adopted t

Schedule of Omitted Supplements to the Pledge Agreement, dated as of November 6, 2006 and amended and restated as of March 2, 2009, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.7(c) Schedule of Omitted Supplements to Pledge Agreement The supplements to the pledge agreement referenced below are substantially identical in all material respects to the Supplement No. 1 dated as of October 27, 2011 to the Pledge Agreement dated as of November 6, 2006, and amended and restated as of March 2, 2009, as supplemented (the “Pledge Agreement”) and filed as Exhibit 4.7(b) t

Form of 2024 Performance Share Unit Award Agreement Under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.*

Exhibit 10.44 Form of HCA Healthcare, Inc. Performance Share Unit Agreement This PERFORMANCE SHARE UNIT AGREEMENT (this “Agreement”) is made and entered into as of the day of , 20 (the “Grant Date”), between HCA Healthcare, Inc., a Delaware corporation (together with its Subsidiaries, Successors and other applicable Service Recipients, as applicable, the “Company”), and [Participant Name], (the “G

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11239 HCA Healthcare, I

Schedule of Omitted Supplements to the U.S. Guarantee, dated as of November 17, 2006 and amended and restated on February 26, 2014, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.5(k) Schedule of Omitted Supplements to U.S. Guarantee Agreement The supplements to the U.S. guarantee agreement referenced below are substantially identical in all material respects to the Supplement No. 14 dated as of November 9, 2015 to the U.S. Guarantee dated as of November 17, 2006, as amended and restated as of February 26, 2014, as supplemented (the “U.S. Guarantee Agreement”) an

Schedule of Omitted Supplements to the Security Agreement dated as of September 30, 2011, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.9(c) Schedule of Omitted Supplements to Security Agreement The supplements to the security agreement referenced below are substantially identical in all material respects to the Supplement No. 1 dated as of October 27, 2011 to the Security Agreement dated as of September 30, 2011, as supplemented (the “Security Agreement”) and filed as Exhibit 4.9(b) to the Company’s annual report on For

List of Subsidiaries.

Exhibit 21 ALABAMA CareOne Home Health Services, Inc. Four Rivers Medical Center PHO, Inc. Selma Medical Center Hospital, Inc. ALASKA Alaska IPS Medical Services, LLC Alaska Regional Medical Group, LLC Alaska Spine Center, LLC Anchorage Inpatient Services, LLC Anchorage Intensivist Services, LLC Anchorage Post Acute Services, LLC Anchorage Pulmonary Services, LLC Anchorage Surgicenter, LLC Chugach

Form of 2024 Stock Appreciation Right Award Agreement under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.*

Exhibit 10.43 Form of HCA Healthcare, Inc. Stock Appreciation Rights Agreement This STOCK APPRECIATION RIGHTS AGREEMENT (the “Agreement”), dated as of (the “Grant Date”) is made by and between HCA Healthcare, Inc., a Delaware corporation (together with its Subsidiaries, Successors and other applicable Service Recipients, hereinafter referred to as the “Company”), and the individual whose name is s

HCA / HCA Healthcare, Inc. / HERCULES HOLDING II - SC 13G/A Passive Investment

SC 13G/A 1 d738648dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 13)* HCA Healthcare, Inc. (as successor to HCA Inc.) (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 40412C101 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filin

HCA / HCA Healthcare, Inc. / FRIST THOMAS F JR - SC 13G/A Passive Investment

SC 13G/A 1 d739349dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.13)* HCA Healthcare, Inc. (as successor to HCA Inc.) (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 40412C101 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing

HCA / HCA Healthcare, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01088-hcahealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: HCA Healthcare Inc Title of Class of Securities: Common Stock CUSIP Number: 40412C101 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designat

HCA / HCA Healthcare, Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* HCA Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 40412C101 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to

HCA HEALTHCARE REPORTS FOURTH QUARTER 2023 RESULTS AND PROVIDES 2024 GUIDANCE BILL RUTHERFORD TO RETIRE AND MIKE MARKS TO BECOME CFO

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS FOURTH QUARTER 2023 RESULTS AND PROVIDES 2024 GUIDANCE BILL RUTHERFORD TO RETIRE AND MIKE MARKS TO BECOME CFO Nashville, Tenn., January 30, 2024 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth qu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 30, 2024 (January 24, 202

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 30, 2024 (January 24, 2024) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorpora

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 9, 2023 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission F

HCA HEALTHCARE PROVIDES BUSINESS OUTLOOK AHEAD OF INVESTOR DAY

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE PROVIDES BUSINESS OUTLOOK AHEAD OF INVESTOR DAY Nashville, Tenn., November 9, 2023 – HCA Healthcare, Inc. (NYSE:HCA) will host its Investor Day today beginning at 8:00 a.m. CT. A team of HCA Healthcare leaders will offer perspectives on the Company’s financial

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Heal

List of Subsidiary Guarantors and Pledged Securities.

EXHIBIT 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 24, 2023 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission F

HCA HEALTHCARE REPORTS THIRD QUARTER 2023 RESULTS REVISES 2023 GUIDANCE

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT:  MEDIA CONTACT: Frank Morgan  Harlow Sumerford 615-344-2688  615-344-1851 HCA HEALTHCARE REPORTS THIRD QUARTER 2023 RESULTS REVISES 2023 GUIDANCE Nashville, Tenn., October 24, 2023 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2023. Key third quarter metrics (

As Filed With the Securities and Exchange Commission on August 28, 2023

As Filed With the Securities and Exchange Commission on August 28, 2023 Registration No.

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) HCA Healthcare, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcar

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 27, 2023 HCA HEALTHCARE, INC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 27, 2023 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission File

HCA HEALTHCARE REPORTS SECOND QUARTER 2023 RESULTS RAISES 2023 GUIDANCE

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS SECOND QUARTER 2023 RESULTS RAISES 2023 GUIDANCE NASHVILLE, Tenn., July 27, 2023 – HCA Healthcare, Inc. (NYSE:HCA), today announced financial and operating results for the second quarter ended June 30, 2023. Key second quarter metrics (all perce

HCA HEALTHCARE REPORTS DATA SECURITY INCIDENT

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS DATA SECURITY INCIDENT NASHVILLE, Tenn., July 10, 2023 – HCA Healthcare, Inc. (NYSE:HCA) recently discovered that a list of certain information with respect to some of its patients was made available by an unknown and unauthorized party on an on

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 10, 2023 HCA Healthcare, Inc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 10, 2023 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

HCA Healthcare, Inc. HCA Inc. Offer to Exchange $6,000,000,000 aggregate principal amount of Senior Notes Consisting of: $6,000,000,000 aggregate principal amount of Senior Notes Consisting of: $1,000,000,000 3 1/8% Senior Notes due 2027 for $1,000,0

Form 424(b)(3) Table of Contents Filed Pursuant to Rule 424(b)(3) Registration Statement No.

HCA Healthcare, Inc. HCA Inc. One Park Plaza Nashville, Tennessee 37203

SEC Acceleration Request Letter HCA Healthcare, Inc. HCA Inc. One Park Plaza Nashville, Tennessee 37203 June 9, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: HCA Healthcare, Inc. and HCA Inc. Registration Statement on Form S-4 (File No. 333-272298) To Whom It May Concern: With respect to the above-referenced registra

Powers of attorney

Form S-4 Table of Contents As filed with the Securities and Exchange Commission on May 31, 2023 Registration Statement No.

HCA Healthcare, Inc. HCA Inc. One Park Plaza Nashville, Tennessee 37203

CORRESP HCA Healthcare, Inc. HCA Inc. One Park Plaza Nashville, Tennessee 37203 May 31, 2023 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: HCA Healthcare, Inc. and HCA Inc. Registration Statement on Form S-4 (File No. 333-272298), filed on May 31, 2023 Ladies and Gentlemen: On May 31, 2023, HCA Healthcare, Inc. (the “Parent”) and H

Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939, as amended, of Delaware Trust Company, as Trustee under the Indenture dated as of August 11, 2011

EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) Delaware Trust Company (Exact name of trustee as specified in its charter) Delaware 51-0011500 (Jurisdiction

Filing Fee Table

EX-FILING FEES 6 d485255dexfilingfees.htm EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Tables Form S-4 (Form Type) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Proposed Maximum Aggregate Off

Form of Letter of Transmittal

EX-99.1 Exhibit 99.1 THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken you should immediately consult your broker, bank manager, lawyer, accountant, investment adviser or other professional adviser. LETTER OF TRANSMITTAL Relating to HCA HEALTHCARE, INC. HCA INC. Offer to Exchange $6,000,000,000 aggregate principal amount of Senio

HCA HEALTHCARE, INC. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Exhibit 99.1 HCA HEALTHCARE, INC. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm F-2 Consolidated Financial Statements: Consolidated Income Statements for the years ended December 31, 2022, 2021 and 2020 F-5 Consolidated Comprehensive Income Statements for the years ended December 31, 2022, 2021 and 2020 F-6 Consolidated Balance Sheets, Dece

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of ea r liest event reported): May 26, 2023 HCA Healthcare, In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of ea r liest event reported): May 26, 2023 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File Nu

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2023 (May 4, 2023) HCA Hea

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2023 (May 4, 2023) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commiss

Supplemental Indenture No. 35, dated as of May 4, 2023, among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed on May 4, 2023, and incorporated herein by reference).

EX-4.3 Exhibit 4.3 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.500% SENIOR NOTES DUE 2033 SUPPLEMENTAL INDENTURE NO. 35 Dated as of May 4, 2023 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Sect

Supplemental Indenture No. 36, dated as of May 4, 2023, among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 4, 2023, and incorporated herein by reference).

EX-4.4 Exhibit 4.4 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.900% SENIOR NOTES DUE 2053 SUPPLEMENTAL INDENTURE NO. 36 Dated as of May 4, 2023 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Sect

Supplemental Indenture No. 34, dated as of May 4, 2023, among HCA Inc., HCA Healthcare, Inc., Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on May 4, 2023, and incorporated herein by reference).

EX-4.2 Exhibit 4.2 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 5.200% SENIOR NOTES DUE 2028 SUPPLEMENTAL INDENTURE NO. 34 Dated as of May 4, 2023 To BASE INDENTURE Dated as of August 1, 2011 CROSS-REFERENCE TABLE* Trust Indenture Act Sect

HCA Inc. $3,250,000,000 Senior Notes Consisting of: $1,000,000,000 5.200% Senior Notes due 2028 $1,250,000,000 5.500% Senior Notes due 2033 $1,000,000,000 5.900% Senior Notes due 2053

Form 424(b)(5) Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No.

Calculation of Filing Fee Tables (Form Type) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

EX-FILING FEES 2 d459534dexfilingfees.htm EX-FILING FEES EXHIBIT 107 Calculation of Filing Fee Tables 424(b)(5) (Form Type) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities The prospectus supplement to which this Exhibit is attached is a final prospectus for the related offering. The maximum aggregate amount of this offering is $3,214

Underwriting Agreement, dated as of May 1, 2023, among HCA Inc., HCA Healthcare, Inc., and BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the other several underwriters named therein.

EX-1.1 Exhibit 1.1 Execution Version HCA INC. $1,000,000,000 5.200% Senior Notes due 2028 $1,250,000,000 5.500% Senior Notes due 2033 $1,000,000,000 5.900% Senior Notes due 2053 UNDERWRITING AGREEMENT May 1, 2023 BofA Securities, Inc. Citigroup Global Markets Inc. J.P. Morgan Securities LLC Wells Fargo Securities, LLC As Representatives of the Underwriters c/o BofA Securities, Inc. One Bryant Park

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 2, 2023 (May 1, 2023) HCA Hea

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 2, 2023 (May 1, 2023) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commiss

Subject to Completion, dated May 1, 2023

Form 424(b)(3) Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No.

As filed with the Securities and Exchange Commission on May 1, 2023

Form S-3ASR Table of Contents As filed with the Securities and Exchange Commission on May 1, 2023 Registration No.

Form T-1 Statement of Eligibility under the Trust Indenture Act of 1939 on Form T-1 of Delaware Trust Company, as trustee under the Indenture dated as of August 1, 2011 and the Indenture dated as of December 6, 2012

EX-25.1 Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b) (2) Delaware Trust Company (Exact name of trustee as specified in its charter) Delaware 51-0011500 (Jurisdiction

Filing Fee Table

EX-FILING FEES 5 d471854dexfilingfees.htm EX-FILING FEES Exhibit 107.1 Calculation of Filing Fee Table Form S-3 (Form Type) HCA Healthcare, Inc. and HCA, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit

HCA Inc. $1,000,000,000 5.200% Senior Notes due 2028 (the “2028 notes”) $1,250,000,000 5.500% Senior Notes due 2033 (the “2033 notes”) $1,000,000,000 5.900% Senior Notes due 2053 (the “2053 notes”) (collectively, the “notes”) Pricing Supplement

FWP Filed pursuant to Rule 433 Issuer Free Writing Prospectus, dated May 1, 2023 Supplementing the Preliminary Prospectus Supplement, dated May 1, 2023 Registration No.

Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthca

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 List of Subsidiary Guarantors All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

HCA HEALTHCARE REPORTS FIRST QUARTER 2023 RESULTS REVISES 2023 GUIDANCE

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS FIRST QUARTER 2023 RESULTS REVISES 2023 GUIDANCE NASHVILLE, Tenn., April 21, 2023 – HCA Healthcare, Inc. (NYSE:HCA), today announced financial and operating results for the first quarter ended March 31, 2023. Key first quarter metrics (all perce

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 21, 2023 HCA HEALTHCARE, IN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 21, 2023 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission Fil

and April 21, 2023

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 21, 2023 (April 19, 2023) HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation

HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 21, 2023, and incorporated herein by reference).*

EX-10.1 Exhibit 10.1 HCA HEALTHCARE, INC. 2023 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. INTRODUCTION 1.1 ESTABLISHMENT OF PLAN. HCA Healthcare, Inc., a Delaware corporation (the “Company”), adopts the following nonqualified employee stock purchase plan for its eligible employees. This Plan shall be known as the HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan. 1.2 PURPOSE. The purpose of this

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 6, 2023 (April 3, 2023) HCA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 6, 2023 (April 3, 2023) HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Com

HCA Healthcare, Inc. 2023 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 6, 2023, and incorporated herein by reference).*

EX-10.1 Exhibit 10.1 HCA HEALTHCARE, INC. 2023 SENIOR OFFICER PERFORMANCE EXCELLENCE PROGRAM Purpose and Administration of the Program The 2023 Senior Officer Performance Excellence Program (the “Program”) has been established by HCA Healthcare, Inc. (the “Company”) to encourage outstanding performance from its senior officers. Awards under the Program shall be administered as “Performance-Based A

This communication is not a solicitation of proxy authority and no proxy cards will be accepted. Vote your proxies in accordance with HCA’s instructions.

Notice of Exempt Solicitation NAME OF REGISTRANT: HCA Healthcare Inc. NAME OF PERSON RELYING ON EXEMPTION: Michael Frerichs, as Trustee of the Bright Start College Savings Trust ADDRESS OF PERSON RELYING ON EXEMPTION: Office of the Illinois State Treasurer, 555 W. Monroe, 14th Floor, Chicago, IL 60661 Written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exc

Schedule 14A

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the app

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State

Signing Bonus Agreement, dated as of January 24, 2022, by and between HCA Healthcare, Inc. and Michael R. McAlevey.*

Exhibit 10.9(i) SIGNING BONUS AGREEMENT This SIGNING BONUS AGREEMENT (this “Agreement”), dated January 24, 2022 (the “Hire Date”), is entered into by and between HCA Healthcare, Inc., a Delaware corporation (the “Company”), and Michael R. McAlevey (“Executive” and, together with the Company, the “Parties”). WHEREAS, in connection with Executive’s employment as Senior Vice President and Chief Legal

Schedule of Omitted Supplements to the Security Agreement, dated as of November 17, 2006 and amended and restated as of March 2, 2009, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.6(c) Schedule of Omitted Supplements to Security Agreement The supplements to the security agreement referenced below are substantially identical in all material respects to the Supplement No. 2 dated as of October 27, 2011 to the Security Agreement dated as of November 17, 2006, amended and restated as of March 2, 2009, as supplemented (the “Security Agreement”) and filed as Exhibit 4.6

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11239 HCA Healthcare, I

Schedule of Omitted Supplements to the Security Agreement dated as of September 30, 2011, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.9(c) Schedule of Omitted Supplements to Security Agreement The supplements to the security agreement referenced below are substantially identical in all material respects to the Supplement No. 1 dated as of October 27, 2011 to the Security Agreement dated as of September 30, 2011, as supplemented (the “Security Agreement”) and filed as Exhibit 4.9(b) to the Company’s annual report on For

Schedule of Omitted Supplements to the U.S. Guarantee, dated as of November 17, 2006 and amended and restated on February 26, 2014, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.5(k) Schedule of Omitted Supplements to U.S. Guarantee Agreement The supplements to the U.S. guarantee agreement referenced below are substantially identical in all material respects to the Supplement No. 14 dated as of November 9, 2015 to the U.S. Guarantee dated as of November 17, 2006, as amended and restated as of February 26, 2014, as supplemented (the “U.S. Guarantee Agreement”) an

Form of 2023 Stock Appreciation Right Award Agreement Under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 10.40 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and incorporated herein by reference).*

Exhibit 10.40 Form of HCA Healthcare, Inc. Stock Appreciation Rights Agreement This STOCK APPRECIATION RIGHTS AGREEMENT (the “Agreement”), dated as of (the “Grant Date”) is made by and between HCA Healthcare, Inc., a Delaware corporation (together with its Subsidiaries, Successors and other applicable Service Recipients, hereinafter referred to as the “Company”), and the individual whose name is s

Description of Registered Securities (filed as Exhibit 4.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and incorporated herein by reference).

Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 HCA Healthcare, Inc. has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock. In this Exhibit 4.1, when we refer to the “Company,” “we,” “us” or “our” or when we otherwise refer to ourselves, we mean HCA

List of Subsidiaries.

Exhibit 21 ALABAMA CareOne Home Health Services, Inc. Four Rivers Medical Center PHO, Inc. Selma Medical Center Hospital, Inc. ALASKA Alaska Regional Medical Group, LLC Alaska Spine Center, LLC Anchorage Surgicenter, LLC Chugach PT, Inc. Columbia Behavioral Healthcare, Inc. SLS Mountain Division, LLC Surgicare of Anchorage, LLC ARIZONA DS Real Estate Holdings, LLC Urgent Care Extra - Ann & Simmons

Form of 2023 Performance Share Unit Award Agreement Under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 10.41 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and incorporated herein by reference).*

Exhibit 10.41 Form of HCA Healthcare, Inc. Performance Share Unit Agreement This PERFORMANCE SHARE UNIT AGREEMENT (this “Agreement”) is made and entered into as of the day of , 20 (the “Grant Date”), between HCA Healthcare, Inc., a Delaware corporation (together with its Subsidiaries, Successors and other applicable Service Recipients, as applicable, the “Company”), and [Participant Name], (the “G

Schedule of Omitted Supplements to the Pledge Agreement, dated as of November 6, 2006 and amended and restated as of March 2, 2009, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.7(c) Schedule of Omitted Supplements to Pledge Agreement The supplements to the pledge agreement referenced below are substantially identical in all material respects to the Supplement No. 1 dated as of October 27, 2011 to the Pledge Agreement dated as of November 6, 2006, and amended and restated as of March 2, 2009, as supplemented (the “Pledge Agreement”) and filed as Exhibit 4.7(b) t

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

HCA / HCA Holdings Inc. / FRIST THOMAS F JR - SC 13G/A Passive Investment

SC 13G/A 1 d431697dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12)* HCA Healthcare, Inc. (as successor to HCA Inc.) (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 40412C101 (CUSIP Number) December 31, 2022 (Date of Event which Requires Filin

HCA / HCA Holdings Inc. / HERCULES HOLDING II - SC 13G/A Passive Investment

SC 13G/A 1 d428395dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 12)* HCA Healthcare, Inc. (as successor to HCA Inc.) (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 40412C101 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filin

HCA / HCA Holdings Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01050-hcahealthcareinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: HCA Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 40412C101 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designa

HCA / HCA Holdings Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* HCA Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 40412C101 (CUSIP Number) December 30, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sched

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 30, 2023 (October 20, 2022) HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdict

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 27, 2023 HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission F

HCA HEALTHCARE REPORTS FOURTH QUARTER 2022 RESULTS AND PROVIDES 2023 GUIDANCE

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS FOURTH QUARTER 2022 RESULTS AND PROVIDES 2023 GUIDANCE Nashville, Tenn., January 27, 2023 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2022. Key fourth quarter metrics (all

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 4, 2023 (January 4, 2023) HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation)

Restatement Agreement dated as of January 4, 2023, by and among HCA Inc., as borrower, the guarantors party thereto, Bank of America, N.A., as administrative agent and collateral agent, and the lenders party thereto (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed January 4, 2023, and incorporated herein by reference).

EX-4.1 2 d428263dex41.htm EX-4.1 Exhibit 4.1 Execution Version RESTATEMENT AGREEMENT, dated as of January 4, 2023 (this “Restatement Agreement”), to the Credit Agreement, dated as of November 17, 2006, as amended and restated as of May 4, 2011, February 26, 2014, June 28, 2017 and June 30, 2021 (as further amended and in effect immediately prior to the Fifth Restatement Effective Date, the “Fourth

Amendment No. 1 to Credit Agreement dated as of January 4, 2023, by and among HCA Inc., as parent borrower, the subsidiary borrowers party thereto, Bank of America, N.A., as administrative agent and collateral agent, and the lenders party thereto (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed January 4, 2023, and incorporated herein by reference).

EX-4.2 3 d428263dex42.htm EX-4.2 Exhibit 4.2 Execution Version AMENDMENT NO. 1 TO CREDIT AGREEMENT, dated as of January 4, 2023 (this “Agreement”), by and among HCA Inc., a Delaware corporation (“HCA” or the “Parent Borrower”), the subsidiary borrowers party hereto (the “Subsidiary Borrowers” and, together with the Parent Borrower, the “Borrowers”), the Lenders party hereto and Bank of America, N.

Third Amended and Restated Bylaws of the Company (filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed December 19, 2022, and incorporated herein by reference).

EX-3.1 Exhibit 3.1 THIRD AMENDED AND RESTATED BYLAWS OF HCA HEALTHCARE, INC. A Delaware Corporation ARTICLE I OFFICES SECTION 1. REGISTERED OFFICE. The registered office of HCA Healthcare, Inc. (the “Corporation”) in the State of Delaware shall be located at Corporation Trust Center, 1209 Orange Street, in the city of Wilmington, County of New Castle, 19801. The name of the Corporation’s registere

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 19, 2022 HCA HEALTHCARE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 19, 2022 HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Heal

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 26, 2022 (October 20, 2022) HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation

HCA HEALTHCARE ANNOUNCES OPERATIONAL REORGANIZATION

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE ANNOUNCES OPERATIONAL REORGANIZATION NASHVILLE, Tenn., October 25, 2022 ? HCA Healthcare, Inc. (NYSE:HCA), one of the nation?s leading healthcare providers, today announced an organizational change that includes the creation of a third operating group. The chan

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 21, 2022 HCA HEALTHCARE,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 21, 2022 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission F

HCA HEALTHCARE REPORTS THIRD QUARTER 2022 RESULTS

EX-99.1 2 d311683dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE REPORTS THIRD QUARTER 2022 RESULTS Nashville, Tenn., October 21, 2022 – HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2022. Key third quarter metric

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 17, 2022 (August 15, 2022) HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporati

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 All of the senior notes issued by HCA Inc. in 2014 or later are fully and unconditionally guaranteed on an unsecured basis by HCA Healthcare, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcar

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 22, 2022 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission File

HCA Healthcare Reports Second Quarter 2022 Results

Exhibit 99.1 INVESTOR CONTACT: FOR IMMEDIATE RELEASE MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare Reports Second Quarter 2022 Results Nashville, Tenn., July 22, 2022 ? HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2022. Key second quarter metrics (all percentage changes compare 2Q 2022

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 25, 2022 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthca

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 List of Subsidiary Guarantors All of the senior secured notes and senior unsecured notes issued by HCA Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 26, 2022 (April 21, 2022) HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation

HCA Healthcare Reports First Quarter 2022 Results Revises 2022 Guidance

Exhibit 99.1 INVESTOR CONTACT: FOR IMMEDIATE RELEASE MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare Reports First Quarter 2022 Results Revises 2022 Guidance Nashville, Tenn., April 22, 2022 ? HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2022. Key first quarter metrics (all percentage ch

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 22, 2022 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission Fil

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 11, 2022 (April 8, 2022) HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Co

HCA Healthcare, Inc. 2022 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 11, 2022, and incorporated herein by reference).*

Exhibit 10.1 HCA HEALTHCARE, INC. 2022 SENIOR OFFICER PERFORMANCE EXCELLENCE PROGRAM Purpose and Administration of the Program The 2022 Senior Officer Performance Excellence Program (the ?Program?) has been established by HCA Healthcare, Inc. (the ?Company?) to encourage outstanding performance from its senior officers. Awards under the Program shall be administered as ?Performance-Based Awards? p

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 7, 2022 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

SECURITIES & EXCHANGE COMMISSION WASHINGTON, D.C. 20549 NOTICE OF EXEMPT SOLICITATION (VOLUNTARY SUBMISSION)

SECURITIES & EXCHANGE COMMISSION WASHINGTON, D.C. 20549 NOTICE OF EXEMPT SOLICITATION (VOLUNTARY SUBMISSION) NAME OF REGISTRANT: HCA Healthcare, Inc. NAME OF PERSON RELYING ON EXEMPTION: SOC Investment Group ADDRESS OF PERSON RELYING ON EXEMPTION: 1900 L Street, N.W., Suite 900, Washington, D.C. 20036 Written materials are submitted pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exc

HCA Healthcare, Inc. (HCA)

HCA Healthcare, Inc. (HCA) Shareholder Alert Voluntary submission by John Chevedden, POB 2673, Redondo Beach, CA 90278 HCA Shareholder since 2015 Please Vote for Proposal 4 ? Political Spending Disclosure It is a no brainer to vote for this proposal. The management statement next to this proposal unintentionally makes the case for this proposal. HCA management says, ?The Board oversees our politic

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registran

DEF 14A 1 d294830ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com

Additional Receivables Intercreditor Agreement, dated as of March 9, 2022, by and between Bank of America, N.A., as ABL Collateral Agent, and Bank of America, N.A., as First Lien Collateral Agent (filed as Exhibit 4.15 to the Company’s Current Report on Form 8-K filed March 10, 2022, and incorporated herein by reference).

Exhibit 4.15 ADDITIONAL RECEIVABLES INTERCREDITOR AGREEMENT by and between BANK OF AMERICA, N.A., as ABL Collateral Agent, and BANK OF AMERICA, N.A., as New First Lien Collateral Agent Dated as of March 9, 2022 TABLE OF CONTENTS Page No. ARTICLE 1 DEFINITIONS Section 1.1 Definitions 2 Section 1.2 Rules of Construction 9 ARTICLE 2 LIEN PRIORITY Section 2.1 Priority of Liens 10 Section 2.2 Waiver of

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 9, 2022 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

Supplemental Indenture No. 29, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed March 10, 2022, and incorporated herein by reference).

Exhibit 4.2 HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, THE SUBSIDIARY GUARANTORS NAMED ON SCHEDULES I-A and I-B HERETO, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 3 1/8% Senior Secured Notes due 2027 SUPPLEMENTAL INDENTURE NO. 29 Dated as of March 9, 2022 To BASE INDENTURE Dated as of August 1, 20

Supplemental Indenture No. 31, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed March 10, 2022, and incorporated herein by reference).

Exhibit 4.4 HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, THE SUBSIDIARY GUARANTORS NAMED ON SCHEDULES I-A and I-B HERETO, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 3 5/8% Senior Secured Notes due 2032 SUPPLEMENTAL INDENTURE NO. 31 Dated as of March 9, 2022 To BASE INDENTURE Dated as of August 1, 20

Supplemental Indenture No. 33, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.6 to the Company’s Current Report on Form 8-K filed March 10, 2022, and incorporated herein by reference).

Exhibit 4.6 HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, THE SUBSIDIARY GUARANTORS NAMED ON SCHEDULES I-A and I-B HERETO, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 4 5/8% Senior Secured Notes due 2052 SUPPLEMENTAL INDENTURE NO. 33 Dated as of March 9, 2022 To BASE INDENTURE Dated as of August 1, 20

Supplemental Indenture No. 30, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed March 10, 2022, and incorporated herein by reference).

EX-4.3 3 d312703dex43.htm EX-4.3 Exhibit 4.3 HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, THE SUBSIDIARY GUARANTORS NAMED ON SCHEDULES I-A and I-B HERETO, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 3 3/8% Senior Secured Notes due 2029 SUPPLEMENTAL INDENTURE NO. 30 Dated as of March 9, 2022 To BASE I

Registration Rights Agreement, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein and Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as representatives of the other several initial purchasers named therein (filed as Exhibit 4.16 to the Company’s Current Report on Form 8-K filed March 10, 2022, and incorporated herein by reference).

Exhibit 4.16 REGISTRATION RIGHTS AGREEMENT Dated as of March 9, 2022 Among HCA INC. HCA HEALTHCARE, INC. THE GUARANTORS PARTY HERETO and CITIGROUP GLOBAL MARKETS INC. BOFA SECURITIES, INC. J.P. MORGAN SECURITIES LLC MORGAN STANLEY & CO. LLC BARCLAYS CAPITAL INC. CAPITAL ONE SECURITIES, INC. GOLDMAN SACHS & CO. LLC MIZUHO SECURITIES USA LLC RBC CAPITAL MARKETS, LLC SMBC NIKKO SECURITIES AMERICA, IN

Supplemental Indenture No. 32, dated as of March 9, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.5 to the Company’s Current Report on Form 8-K filed March 10, 2022, and incorporated herein by reference).

Exhibit 4.5 HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, THE SUBSIDIARY GUARANTORS NAMED ON SCHEDULES I-A and I-B HERETO, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 4 3/8% Senior Secured Notes due 2042 SUPPLEMENTAL INDENTURE NO. 32 Dated as of March 9, 2022 To BASE INDENTURE Dated as of August 1, 20

Purchase Agreement, dated as of March 2, 2022, among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein and Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as representatives of the other several initial purchasers named therein.

EX-10.1 2 d286008dex101.htm EX-10.1 Exhibit 10.1 Execution Version HCA INC. $1,000,000,000 3 1/8% Senior Secured Notes due 2027 $500,000,000 3 3/8% Senior Secured Notes due 2029 $2,000,000,000 3 5/8% Senior Secured Notes due 2032 $500,000,000 4 3/8% Senior Secured Notes due 2042 $2,000,000,000 4 5/8% Senior Secured Notes due 2052 PURCHASE AGREEMENT March 2, 2022 Citigroup Global Markets Inc. BofA

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 3, 2022 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

HCA ANNOUNCES PROPOSED PRIVATE OFFERING OF SENIOR SECURED NOTES

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA ANNOUNCES PROPOSED PRIVATE OFFERING OF SENIOR SECURED NOTES NASHVILLE, Tenn., March 2, 2022 ? HCA Healthcare, Inc. (NYSE: HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior secured notes, subject to market and other considerations. A

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 2, 2022 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 2, 2022 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

Form of 2022 Performance Share Unit Award Agreement Under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 10.39 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and incorporated herein by reference).*

Exhibit 10.39 Form of HCA Healthcare, Inc. Performance Share Unit Agreement This PERFORMANCE SHARE UNIT AGREEMENT (this ?Agreement?) is made and entered into as of the day of , 20 (the ?Grant Date?), between HCA Healthcare, Inc., a Delaware corporation (together with its Subsidiaries, Successors and other applicable Service Recipients, as applicable, the ?Company?), and [Participant Name], (the ?G

Schedule of Omitted Supplements to the U.S. Guarantee, dated as of November 17, 2006 and amended and restated on February 26, 2014, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.5(k) Schedule of Omitted Supplements to U.S. Guarantee Agreement The supplements to the U.S. guarantee agreement referenced below are substantially identical in all material respects to the Supplement No. 14 dated as of November 9, 2015 to the U.S. Guarantee dated as of November 17, 2006, as amended and restated as of February 26, 2014, as supplemented (the ?U.S. Guarantee Agreement?) an

Schedule of Omitted Supplements to the Security Agreement dated as of September 30, 2011, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.9(c) Schedule of Omitted Supplements to Security Agreement The supplements to the security agreement referenced below are substantially identical in all material respects to the Supplement No. 1 dated as of October 27, 2011 to the Security Agreement dated as of September 30, 2011, as supplemented (the ?Security Agreement?) and filed as Exhibit 4.9(b) to the Company?s annual report on For

Schedule of Omitted Supplemental Indentures to Supplemental Indentures, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.26(c) Schedule of Omitted Supplemental Indentures to Supplemental Indentures relating to the Company?s Senior Secured Notes 4.75% Senior Secured Notes due 2023 (Sixth Supplemental Indenture) The supplemental indentures referenced below are substantially identical in all material respects to the Supplemental Indenture, dated as of March 31, 2020 (the ?Supplement to the Sixth Supplemental

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 List of Subsidiary Guarantors All of the senior secured notes and senior unsecured notes issued by HCA Inc.

Form of 2022 Stock Appreciation Right Award Agreement Under the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (filed as Exhibit 10.38 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, and incorporated herein by reference).*

Exhibit 10.38 Form of HCA Healthcare, Inc. Stock Appreciation Rights Agreement This STOCK APPRECIATION RIGHTS AGREEMENT (the ?Agreement?), dated as of (the ?Grant Date?) is made by and between HCA Healthcare, Inc., a Delaware corporation (together with its Subsidiaries, Successors and other applicable Service Recipients, hereinafter referred to as the ?Company?), and the individual whose name is s

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Or ☐ TRANSITION REPORT PUR

Table of Contents Index to Financial Statements Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

List of Subsidiaries.

Exhibit 21 ALABAMA CareOne Home Health Services, Inc. Four Rivers Medical Center PHO, Inc. Selma Medical Center Hospital, Inc. ALASKA Alaska Regional Medical Group, LLC Alaska Spine Center, LLC Anchorage Surgicenter, LLC Chugach PT, Inc. Columbia Behavioral Healthcare, Inc. SLS Mountain Division, LLC Surgicare of Anchorage, LLC ARIZONA DS Real Estate Holdings, LLC Urgent Care Extra - Ann & Simmons

Schedule of Omitted Supplements to the Security Agreement, dated as of November 17, 2006 and amended and restated as of March 2, 2009, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.6(c) Schedule of Omitted Supplements to Security Agreement The supplements to the security agreement referenced below are substantially identical in all material respects to the Supplement No. 2 dated as of October 27, 2011 to the Security Agreement dated as of November 17, 2006, amended and restated as of March 2, 2009, as supplemented (the ?Security Agreement?) and filed as Exhibit 4.6

Schedule of Omitted Supplements to the Pledge Agreement, dated as of November 6, 2006 and amended and restated as of March 2, 2009, filed pursuant to Instruction 2 to Item 601 of Regulation S-K.

Exhibit 4.7(c) Schedule of Omitted Supplements to Pledge Agreement The supplements to the pledge agreement referenced below are substantially identical in all material respects to the Supplement No. 1 dated as of October 27, 2011 to the Pledge Agreement dated as of November 6, 2006, and amended and restated as of March 2, 2009, as supplemented (the ?Pledge Agreement?) and filed as Exhibit 4.7(b) t

HCA / HCA Holdings Inc. / HERCULES HOLDING II - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11)* HCA Healthcare, Inc. (as successor to HCA Inc.) (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 40412C101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropri

HCA / HCA Holdings Inc. / FRIST THOMAS F JR - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 11)* HCA Healthcare, Inc. (as successor to HCA Inc.) (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 40412C101 (CUSIP Number) December 31, 2021 (Date of Event which Requires Filing of this Statement) Check the appropri

HCA / HCA Holdings Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: HCA Healthcare Inc. Title of Class of Securities: Common Stock CUSIP Number: 40412C101 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☒

HCA / HCA Holdings Inc. / WELLINGTON MANAGEMENT GROUP LLP - SEC SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* HCA Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 40412C101 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sch

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 27, 2022 (January 24, 2022) HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorpora

HCA HEALTHCARE APPOINTS ANDREA SMITH AS NEW INDEPENDENT DIRECTOR

Exhibit 99.2 FOR IMMEDIATE RELEASE INVESTOR CONTACTS: MEDIA CONTACT: Mark Kimbrough, Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA HEALTHCARE APPOINTS ANDREA SMITH AS NEW INDEPENDENT DIRECTOR Nashville, Tenn., January 26, 2022 ? HCA Healthcare, Inc. (NYSE: HCA), one of the nation?s leading healthcare providers, today announced that its board of directors has appointed Andrea B. Smith

HCA Healthcare Reports Fourth Quarter 2021 Results and Provides 2022 Guidance Company Increases Capital Spending, Authorizes Additional Share Repurchase Program and Increases Quarterly Dividend

EX-99.1 2 d292652dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACTS: MEDIA CONTACT: Mark Kimbrough, Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare Reports Fourth Quarter 2021 Results and Provides 2022 Guidance Company Increases Capital Spending, Authorizes Additional Share Repurchase Program and Increases Quarterly Dividend Nashville, Tenn., January 27,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION R

Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 List of Subsidiary Guarantors All of the senior secured notes and senior unsecured notes issued by HCA Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 27, 2021 (October 21, 2021) HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorpora

HCA Healthcare Reports Third Quarter 2021 Results; Revises 2021 Guidance

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare Reports Third Quarter 2021 Results; Revises 2021 Guidance Nashville, Tenn., October 22, 2021 ? HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2021. Key third quarter metrics (all perc

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 22, 2021 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission F

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Or ☐ TRANSITION REPORT

Table of Contents Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

List of Subsidiary Guarantors and Pledged Securities.

Exhibit 22 List of Subsidiary Guarantors All of the senior secured notes and senior unsecured notes issued by HCA Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 27, 2021 HCA HEALTHCARE, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File

HCA Healthcare Appoints Hugh F. Johnston as New Independent Director

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: Mark Kimbrough 615-344-2688 MEDIA CONTACT: Harlow Sumerford 615-344-1851 HCA Healthcare Appoints Hugh F. Johnston as New Independent Director NASHVILLE, Tenn., July 27, 2021 ? HCA Healthcare, Inc. (NYSE: HCA) today announced that its board of directors has appointed Hugh F. Johnston as an independent director, effective September 1, 2021. With h

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 20, 2021 HCA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 001-11239 27-3865930 (State or other jurisdiction of incorporation) (Commission File

HCA Healthcare Reports Second Quarter 2021 Results; Raises 2021 Guidance

Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare Reports Second Quarter 2021 Results; Raises 2021 Guidance Nashville, Tenn., July 20, 2021 ? HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2021. Key second quarter metrics (all percentage

Additional Receivables Intercreditor Agreement, dated as of June 30, 2021, by and between Bank of America, N.A., as ABL Collateral Agent, and Bank of America, N.A., as First Lien Collateral Agent (filed as Exhibit 4.9 to the Company’s Current Report on Form 8-K filed July 1, 2021, and incorporated herein by reference).

Exhibit 4.9 EXECUTION VERSION ADDITIONAL RECEIVABLES INTERCREDITOR AGREEMENT by and between BANK OF AMERICA, N.A., as ABL Collateral Agent, and BANK OF AMERICA, N.A., as New First Lien Collateral Agent Dated as of June 30, 2021 TABLE OF CONTENTS Page No. ARTICLE 1 DEFINITIONS Section 1.1 Definitions 2 Section 1.2 Rules of Construction 9 ARTICLE 2 LIEN PRIORITY Section 2.1 Priority of Liens 10 Sect

Restatement Agreement, dated as of June 30, 2021, to the Credit Agreement, dated as of November 17, 2006, by and among HCA Inc., as borrower, the guarantors party thereto, Bank of America, N.A., as administrative agent and collateral agent, and the lenders party thereto (filed as Exhibit 4.10 to the Company’s Current Report on Form 8-K filed July 1, 2021, and incorporated herein by reference).

EX-4.10 5 d191036dex410.htm EX-4.10 Exhibit 4.10 EXECUTION VERSION RESTATEMENT AGREEMENT, dated as of June 30, 2021 (this “Restatement Agreement”), to the Credit Agreement, dated as of November 17, 2006, as amended and restated as of May 4, 2011, February 26, 2014 and June 28, 2017 (as further amended and in effect immediately prior to the Fourth Restatement Effective Date, the “Third Restated Cre

Restatement Agreement, dated as of June 30, 2021, to the Credit Agreement, dated as of September 30, 2011, by and among HCA Inc., as parent borrower, the subsidiary borrowers party thereto, Bank of America, N.A., as administrative agent and collateral agent, and the lenders party thereto (filed as Exhibit 4.11 to the Company’s Current Report on Form 8-K filed July 1, 2021, and incorporated herein by reference).

Exhibit 4.11 EXECUTION VERSION RESTATEMENT AGREEMENT, dated as of June 30, 2021 (this ?Restatement Agreement?), to the Credit Agreement, dated as of September 30, 2011 (the ?Original Credit Agreement?), as amended and restated as of March 7, 2014 (the ?First Restated Credit Agreement?) and as amended and restated as of June 28, 2017 (as in effect immediately prior to the Third Restatement Effectiv

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 30, 2021 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in Charter) Delaware 001-11239 27-3865930 (State or Other Jurisdiction of Incorporation) (Commission File Num

Supplemental Indenture No. 28, dated as of June 30, 2021, by and among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed July 1, 2021, and incorporated herein by reference).

Exhibit 4.3 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, THE SUBSIDIARY GUARANTORS NAMED ON SCHEDULES I-A and I-B HERETO, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 31/2% Senior Secured Notes due 2051 SUPPLEMENTAL INDENTURE NO. 28 Dated as of June 30, 2021 To BASE INDENTURE Dated a

Supplemental Indenture No. 27, dated as of June 30, 2021, by and among HCA Inc., HCA Healthcare, Inc., the subsidiary guarantors named therein, Delaware Trust Company, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed July 1, 2021, and incorporated herein by reference).

Exhibit 4.2 Execution Version HCA INC., as Issuer, HCA HEALTHCARE, INC., as Parent Guarantor, THE SUBSIDIARY GUARANTORS NAMED ON SCHEDULES I-A and I-B HERETO, DELAWARE TRUST COMPANY, as Trustee, and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Paying Agent, Registrar and Transfer Agent 23/8% Senior Secured Notes due 2031 SUPPLEMENTAL INDENTURE NO. 27 Dated as of June 30, 2021 To BASE INDENTURE Dated a

CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered Proposed maximum offering price per security Proposed maximum aggregate offering price Amount of registration fee(1) 2 3/8% Senior Secured Note

Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-226709 CALCULATION OF REGISTRATION FEE Title of each class of securities to be registered Amount to be registered Proposed maximum offering price per security Proposed maximum aggregate offering price Amount of registration fee(1) 2 3/8% Senior Secured Notes due 2031 $850,000,000 99.388% $844,798,000 $92,167.46 3 1/2% Senior S

HCA Inc. $850,000,000 2 3/8% Senior Secured Notes due 2031 (the “2031 notes”) $1,500,000,000 3 1/2% Senior Secured Notes due 2051 (the “2051 notes”) (collectively, the “notes”) Pricing Supplement

Filed pursuant to Rule 433 Issuer Free Writing Prospectus, dated June 21, 2021 Supplementing the Preliminary Prospectus Supplement, dated June 21, 2021 Registration No.